These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1747217)

  • 21. Effect of saline infusion on urinary calcium excretion in essential hypertension.
    Nakamura T; Ichikawa S; Sakamaki T; Sato K; Fujie M; Kurashina T; Kato T; Aizawa F; Murata K
    Am J Hypertens; 1991 Feb; 4(2 Pt 1):113-8. PubMed ID: 1826996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary calcium excretion in essential hypertension.
    Young EW; Morris CD; McCarron DA
    J Lab Clin Med; 1992 Oct; 120(4):624-32. PubMed ID: 1402338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study.
    Lind L; Wengle B; Wide L; Ljunghall S
    Am J Hypertens; 1989 Jan; 2(1):20-5. PubMed ID: 2643969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women.
    Heshmati HM; Riggs BL; Burritt MF; McAlister CA; Wollan PC; Khosla S
    J Clin Endocrinol Metab; 1998 Mar; 83(3):751-6. PubMed ID: 9506720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium metabolism in essential hypertension: relationship to altered renin system activity.
    Resnick LM; Nicholson JP; Laragh JH
    Fed Proc; 1986 Nov; 45(12):2739-45. PubMed ID: 3533639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diurnal blood pressure profile in older patients with isolated systolic hypertension. The SYST-EUR Investigators.
    Thijs L; Dabrowska E; Clement D; Fagard R; Laks T; Mancia G; O'Brien E; Omboni S; Parati G; Staessen J
    J Hum Hypertens; 1995 Nov; 9(11):917-24. PubMed ID: 8583472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of moxonidine in elderly patients with resistant hypertension.
    Martin U; Hill C; O' Mahony D
    J Clin Pharm Ther; 2005 Oct; 30(5):433-7. PubMed ID: 16164488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation.
    Dodson PM; Beevers M; Hallworth R; Webberley MJ; Fletcher RF; Taylor KG
    BMJ; 1989 Jan; 298(6668):227-30. PubMed ID: 2493869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disturbed circadian rhythm of urinary albumin excretion in non-dipper type of essential hypertension.
    Nishimura M; Uzu T; Fujii T; Kimura G
    Am J Nephrol; 2002; 22(5-6):455-62. PubMed ID: 12381943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of oral calcium supplementation on blood pressure in patients with previously untreated hypertension: a randomised, double-blind, placebo-controlled, crossover study.
    Galløe AM; Graudal N; Møller J; Bro H; Jørgensen M; Christensen HR
    J Hum Hypertens; 1993 Feb; 7(1):43-5. PubMed ID: 8450520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of manidipine on circadian blood pressure in essential hypertension.
    Nakamura T; Honma H; Kohno I; Tsuruta I; Ishii H; Tamura K
    Blood Press Suppl; 1992; 3():94-101. PubMed ID: 1343299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroid hormone and calcium. A relationship in hypertension.
    Zachariah PK; Schwartz GL; Strong CG; Ritter SG
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):79S-82S. PubMed ID: 3415813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
    Portale AA; Booth BE; Halloran BP; Morris RC
    J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of sodium and potassium supplementation on blood pressure and arterial stiffness: a fully controlled dietary intervention study.
    Gijsbers L; Dower JI; Mensink M; Siebelink E; Bakker SJ; Geleijnse JM
    J Hum Hypertens; 2015 Oct; 29(10):592-8. PubMed ID: 25673113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperfiltration and calcium metabolism in essential hypertension.
    Zoccali C; Mallamaci F; Postorino M; Cuzzola F; Leonardis D; Parlongo S; Salnitro F
    Am J Hypertens; 1991 Dec; 4(12 Pt 1):944-50. PubMed ID: 1815651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypotensive effect of long-term oral calcium supplementation in elderly patients with essential hypertension.
    Tabuchi Y; Ogihara T; Hashizume K; Saito H; Kumahara Y
    J Clin Hypertens; 1986 Sep; 2(3):254-62. PubMed ID: 3097267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [24-Hour blood pressure profile in patients with mild and moderate arterial hypertension and sleep apnea/hypopnea].
    Zelveian PA; Oshchepkova EV; Buniatian MS; Badikov DN; Rogoza AN
    Ter Arkh; 2001; 73(9):8-13. PubMed ID: 11642089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension.
    Franzoni F; Santoro G; Carpi A; Da Prato F; Bartolomucci F; Femia FR; Prattichizzo F; Galetta F
    Biomed Pharmacother; 2005; 59(1-2):25-9. PubMed ID: 15740932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.